Engineers Gate Manager LP Phathom Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$10.26 - $15.7 $132,230 - $202,341
12,888 New
12,888 $133,000
Q3 2021

Nov 15, 2021
SELL
$30.69 - $36.83 $439,173 - $527,037
-14,310 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$32.66 - $39.87 $165,063 - $201,502
5,054 Added 54.6%
14,310 $484,000
Q1 2021

May 17, 2021
BUY
$33.86 - $48.68 $313,408 - $450,582
9,256 New
9,256 $348,000

Others Institutions Holding PHAT

# of Institutions
143
Shares Held
73.6M
Call Options Held
42.3K
Put Options Held
45.7K
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $273M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email